Jazz pays $1bn for rare disease drug developer Gentium
Dublin pharma group continues expansion in specialty therapy sector
Jazz Pharma reported to be seeking $757.2m to refinance debt
Advisors for Dublin-based niche drug business hold meeting in New York today
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices